Oncotelic Therapeutics, Inc. (OTCMKTS:OTLC – Get Free Report) saw a significant increase in short interest in the month of October. As of October 15th, there was short interest totalling 48,300 shares, an increase of 11,975.0% from the September 30th total of 400 shares. Based on an average daily volume of 1,450,400 shares, the short-interest ratio is presently 0.0 days.
Oncotelic Therapeutics Price Performance
Shares of OTCMKTS:OTLC opened at $0.04 on Friday. Oncotelic Therapeutics has a 12 month low of $0.02 and a 12 month high of $0.05. The company has a debt-to-equity ratio of 0.19, a quick ratio of 0.01 and a current ratio of 0.01. The company’s fifty day simple moving average is $0.02 and its 200 day simple moving average is $0.03.
About Oncotelic Therapeutics
Featured Stories
- Five stocks we like better than Oncotelic Therapeutics
- ESG Stocks, What Investors Should Know
- Lam Research Proves Analysts Wrong with a Strong Earnings Report
- 3 Healthcare Dividend Stocks to Buy
- PureCycle: Up 250% in 2024 – Is This Materials Stock Still a Buy?
- 10 Best Airline Stocks to Buy
- MarketBeat Week in Review – 10/21- 10/25
Receive News & Ratings for Oncotelic Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oncotelic Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.